Opportunity
Simpler Grants.gov #FOR-AI-27-007
NIAID Solicitation for Clinical Trial Implementation Cooperative Agreements
Buyer
National Institutes of Health
Posted
June 27, 2025
Respond By
February 25, 2026
Identifier
FOR-AI-27-007
NAICS
541715
This opportunity from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), seeks applications for cooperative agreements to implement high-risk clinical trials. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) - Scope of Work: - Supports investigator-initiated, milestone-driven clinical trials, including mechanistic studies - Encompasses both basic and clinical research - Funding covers: - Conduct, completion, and analysis of clinical trials - Training of study personnel - Subject recruitment and enrollment - Data collection and management - Investigational product costs - Laboratory work and analyses - Study management and oversight - Post-trial activities - Regulatory compliance and site monitoring - Eligibility: - Open to government entities, nonprofits, educational institutions, and businesses - Notable Requirements: - No specific OEMs or vendors are named, as this is a grant for research and clinical trial implementation - Applicants must propose high-risk, milestone-driven clinical trials - Includes support for both direct trial costs and related research activities
Description
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to support the implementation of investigator-initiated, milestone driven, high-risk clinical trials including mechanistic studies. The program supports the conduct, completion, and analysis of clinical trials, as well as related activities such as training, enrollment, data management, investigational product costs, laboratory work, study management, post-trial activities, regulatory activities, and site monitoring. This cooperative agreement encompasses both basic and clinical research to advance NIAID's mission.